Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
New treatment for inflammatory bowel disease lands Microbiotica €42 million - EU-Startups
Microbiotica is developing a new treatment for inflammatory bowel disease. The company has secured €42 million in funding to advance its novel therapies. This funding will support the progression of their pipeline and further research into gut microbiome-based treatments.
New treatment for inflammatory bowel disease lands Microbiotica €42 million EU-Startups
| Nov 03, 2026 | Clinics On Cloud | $14.4M | — | India |
| Nov 03, 2026 | Zafrens | $6.0M | Series A | United States |
| Nov 03, 2026 | Aioss | $1.1M | Seed | Denmark |
| Nov 02, 2026 | Activ Surgical | $45.0M | Series B | United States |
You just read who funded Microbiotica. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.